NASDAQ$AMED

Amedisys Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

Amedisys reported financial results for Q1 2024, showing increased net service revenue but decreased net income compared to the previous year. Adjusted EBITDA and adjusted net income also increased.

Amedisys reported a mixed performance for Q1 2024. Net service revenue increased to $571.4 million, but net income decreased to $14.4 million due to merger-related expenses. Adjusted EBITDA and adjusted net income showed improvements compared to Q1 2023.

  • Net service revenue increased by $15.0 million to $571.4 million compared to Q1 2023.
  • Net income attributable to Amedisys, Inc. decreased to $14.4 million, inclusive of $20.7 million in merger-related expenses.
  • Adjusted EBITDA increased to $59.9 million compared to $57.8 million in Q1 2023.
  • Adjusted net income attributable to Amedisys, Inc. increased to $33.9 million compared to $32.7 million in Q1 2023.

Headline financials

Total Revenue

$571M

Previous: $556M+2.7%
EPS (adj)

$1.03

Previous: $1.00+3.0%
Days Revenue Outstanding

54.1%

No prior period
Capital Expenditures

-$2.89M

Previous: $1.35M-314.3%
Net Income

$14.4M

Previous: $25.2M-43.0%
Operating Income

$31.6M

Previous: $42.4M-25.4%
Gross Profit

$118M

Previous: $241M-51.3%
Stock-Based Comp

$7.89M

Previous: $3.27M+140.9%

Revenue & EPS history

Amedisys · Revenue · Quarterly

$571M

Q1 2024+2.7%vs Q1 2023
Beat estimate in 6 of 15 quarters(40%)
ActualEstimate

Forward guidance

Amedisys has a pending merger with UnitedHealth Group Incorporated and will not conduct a quarterly earnings call.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 15 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

-0.6%

Avg return

Earnings day

-0.5%

Avg return

5 days after

-5.0%

Avg return

30 days after

46%

32 / 70 earnings

Positive

+25.6%

Q2 2014

Best reaction

-25.3%

Q3 2013

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025
Q3 2025
Q2 2025+1.2%+1.0%
Q1 2025+0.2%-0.8%-1.6%
Q4 2024+0.1%+0.6%+1.5%
Q3 2024+0.9%-3.4%-10.4%
Q2 2024+0.0%+0.5%-0.2%
Q1 2024+0.0%+0.8%+5.5%
Q4 2023+0.9%+0.6%-1.6%
Q3 2023-0.8%-1.1%+1.8%
Q2 2023-0.6%-0.2%+2.5%
Q1 2023+4.2%+3.9%+2.8%
Q4 2022+5.4%+2.2%-23.6%
Q3 2022-9.0%-4.2%-10.7%
Q2 2022-3.8%+0.9%-4.5%
Q1 2022+0.4%-3.3%-10.5%
Q4 2021+5.8%+14.5%+18.4%
Q3 2021+0.1%+1.7%-20.2%
Q2 2021-22.8%-22.9%-29.3%
Q1 2021+0.2%
Q4 2020-6.2%
Q3 2020-1.9%
Q2 2020+3.7%
Q1 2020-3.3%
Q4 2019-2.1%
Q3 2019-1.5%
Q2 2019-1.9%
Q1 2019-6.3%
Q4 2018+0.0%
Q3 2018+17.3%
Q2 2018+11.1%
Q1 2018+7.2%
Q4 2017+2.3%
Q3 2017+4.8%
Q2 2017-20.9%
Q1 2017+4.4%
Q4 2016+4.7%
Q3 2016-10.1%
Q2 2016-7.1%
Q1 2016-7.0%
Q4 2015+12.3%
Q3 2015+10.8%
Q2 2015-3.2%
Q1 2015+6.0%
Q4 2014-5.4%
Q3 2014+16.2%
Q2 2014+25.6%
Q1 2014-1.0%
Q4 2013-10.0%
Q3 2013-25.3%
Q2 2013+17.8%
Q1 2013-2.8%
Q4 2012-8.7%
Q3 2012-5.0%
Q2 2012+12.5%
Q1 2012-1.2%
Q4 2011-0.6%
Q3 2011-23.8%
Q2 2011-10.7%
Q1 2011-6.4%
Q4 2010-8.0%
Q3 2010+1.3%
Q2 2010-7.9%
Q1 2009-4.3%
Q1 2010+2.6%
Q4 2007-1.3%
Q4 2009-1.3%
Q3 2008-5.7%
Q3 2009-5.7%
Q4 2008+7.6%
Q2 2008+7.6%
Q2 2009+7.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro